NCT04199416 is a NA clinical trial of mRehab app in Knee Pain/Osteoarthritis, sponsored by The University of Hong Kong.

Who is sponsoring NCT04199416?

NCT04199416 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT04199416?

Interventions in NCT04199416: mRehab app, Sham app.

What condition does NCT04199416 study?

NCT04199416 studies Knee Pain/Osteoarthritis, Digital Health.

Is NCT04199416 still recruiting?

NCT04199416 is currently status unknown. Last updated 6 November 2020.

Last reviewed 2020-11-06 · How we verify

NCT04199416

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of a Mobile App for Individuals With or at Risk of Knee Osteoarthritis

Status unknown NA Last updated 6 November 2020

What this trial tests

NA trial testing mRehab app in Knee Pain/Osteoarthritis in 320 participants. Status unknown.

Timeline

1 January 2021

Primary endpoint
31 March 2023

31 March 2023

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	320
Start date	1 January 2021
Primary completion	31 March 2023
Estimated completion	31 March 2023
Sites	3 locations across Hong Kong

Drugs / interventions tested

mRehab app
Sham app

Conditions studied

Knee Pain/Osteoarthritis — all drugs for Knee Pain/Osteoarthritis →
Digital Health — all drugs for Digital Health →

Sponsor

The University of Hong Kong

Who can join

50 and older, any sex, with Knee Pain/Osteoarthritis or Digital Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To develop and examine an interactive, multi-functional mobile app-based technology designed to encourage endogenous health care using a 12-month randomized controlled trial to demonstrate whether knee osteoarthritis (KOA)-at-risk individuals and KOA-diagnosed patients can improve their knee pain, physical function, and other relevant outcomes by using the technology to support knee/KOA self-management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04199416 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 6 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04199416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing